SEC fundamentals

ADIAL PHARMACEUTICALS, INC. (AZR)

as filed in 10-Q FY2026, period ended Sep 30, 2026 · updated Nov 14, 2026
Total Assets
$22.5M
Stockholders' Equity
-$21.1M
Cash & Equivalents
$22.0M
Long-Term Debt
—

as filed in 10-Q FY2026, period ended Sep 30, 2026 · View filings on EDGAR ↗

Quarter-end price

Derived from SEC filings · not a live quote · USD per share

Dec 31, 2025
$0.2200
From 23 filers
Mar 31, 2026
$1.79
From 15 filers
Jun 30, 2026
$2.56
From 17 filers
Sep 30, 2026
$4.01
As reported

33 quarter-ends on file; the newest 4 shown. Each price is as of its date, from the filings that reported it, and is never adjusted; the full series with each price's sources is in the docs.

In its 10-Q for the period ended Sep 30, 2026, ADIAL PHARMACEUTICALS, INC. reported net income of -$64.6M and total assets of $22.5M. Every figure below is taken directly from ADIAL PHARMACEUTICALS, INC.'s SEC filings: each links to the source document on EDGAR.

Revenue and net income by fiscal year

As reported in each year’s annual filing · USD

Fiscal yearRevenueNet income
FY2025—-$8.0M
FY2024—-$13.2M
FY2023—-$5.1M
FY2022—-$12.7M
FY2021—-$19.4M
FY2020—-$10.9M
FY2019—-$8.6M
FY2018—-$11.6M
FY2017—-$1.1M

Recent SEC filings

Filed by the registrant · newest first · insider forms and holder schedules not included

FormFiledSource
8-KNov 12, 2026on EDGAR ↗
10-QNov 12, 2026on EDGAR ↗
8-KNov 9, 2026on EDGAR ↗
8-KOct 28, 2026on EDGAR ↗
10-Q/AOct 21, 2026on EDGAR ↗
8-KOct 16, 2026on EDGAR ↗
8-KOct 2, 2026on EDGAR ↗
8-KSep 18, 2026on EDGAR ↗
8-KSep 16, 2026on EDGAR ↗
8-KAug 25, 2026on EDGAR ↗

All filings on EDGAR ↗

Balance Sheet

as of Sep 30, 2026 · 10-Q

Total Assets$22.5Msource ↗
Stockholders’ Equity-$21.1Msource ↗
Cash & Equivalents$22.0Msource ↗
Long-Term Debt—source ↗

Income Statement

10-Q (quarterly) · period ended Sep 30, 2026

Revenue—source ↗
Net Income-$64.6Msource ↗
Operating Income-$7.5Msource ↗
Gross Profit—source ↗
Cost of Revenue—source ↗
R&D Expense$1.8Msource ↗

Per Share & Cash Flow

10-Q (quarterly) · period ended Sep 30, 2026

EPS (diluted)$-4.52source ↗
EPS (basic)$-4.52source ↗
Shares Outstanding14.3Msource ↗
Cash from Operations-$6.6Msource ↗
Cash from Financing-$35,000source ↗
Cash from Investing$0source ↗

Insider activity

Form 4 open-market activity, last 180 days

Buys
5
Sells
0
Net shares
+40.0K

Restatement history

Point-in-time

3 of 174 annual fact-keys were materially restated between filings: what ADIAL PHARMACEUTICALS, INC. first reported differed from what it later filed. We keep every vintage of every annual figure, each keyed to its EDGAR accession.

See each original-vs-restated value, and query any company as of any past date, with the point-in-time API.

Deeper fundamentals

A free API key reaches AZR’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Starter extends the ratios to 20 quarters and adds the Piotroski F-score and accruals quality score; Analyst extends the trajectory to up to 20 years. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Starter removes that cap and adds the original-vs-restated detail, across the whole SEC universe.

Programmatic access

Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.

These fundamentals, as filed
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/AZR

MCP tool: get_sec_fundamentals ticker=AZR

The same figures as they were known on any past date
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/AZR/as-of/YYYY-MM-DD

MCP tool: get_asof_fundamentals ticker=AZR as_of=YYYY-MM-DD

Quarter-end prices derived from SEC filings, with their sources and splits
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/prices/AZR/history?frequency=quarter

MCP tool: get_sec_price_history ticker=AZR frequency=quarter

Fiscal-year trajectory: revenue, margins, free cash flow
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/AZR/history

MCP tool: get_fundamentals_history ticker=AZR

Leverage, liquidity, margin and return ratios
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/financial-health/AZR

MCP tool: get_financial_health ticker=AZR

Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.